The emerging role of unmetabolized folic acid in human diseases: Myth or reality?

Current Drug Metabolism

Volumn 13, Issue 8, 2012, Pages 1184-1195

  Obeid, Rima ^a   Herrmann, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cancer; Folic acid; Fortification; Metabolism; Pregnancy

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALCOHOL; CYANOCOBALAMIN; DIHYDROFOLATE REDUCTASE; DIHYDROFOLIC ACID; FOLIC ACID; FOLINIC ACID; METHOTREXATE; PLACEBO; PROTON COUPLED FOLATE TRANSPORTER; PYRIDOXINE; RIBOFLAVIN; SOMATOMEDIN B;

AGE; ANALYTICAL ERROR; ARTICLE; ASTHMA; BLOOD SAMPLING; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DNA DAMAGE; DNA METHYLATION; DNA POLYMORPHISM; DNA SYNTHESIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG METABOLISM; ENZYME ACTIVATION; ENZYME POLYMORPHISM; ERYTHROCYTE; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISOTOPE LABELING; LIVER METABOLISM; MEAN CORPUSCULAR VOLUME; MEGALOBLASTIC ANEMIA; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEURAL TUBE DEFECT; PH; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PROGENY; PUERPERIUM; RESPIRATORY TRACT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; VERY LOW BIRTH WEIGHT; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

ANIMALS; DIETARY SUPPLEMENTS; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; VITAMIN B COMPLEX;

EID: 84868036099     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012802850137     Document Type: Article

References (100)

1. Bhandari, S.D.; Gregory, J.F., III Folic acid, 5-methyltetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J. Nutr., 1992, 122(9), 1847-1854.
2. Pietrzik, K.; Bailey, L.; Shane, B. Folic acid and L-5- methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet., 2010, 49(8), 535-548.
3. Berry, R.J.; Bailey, L.; Mulinare, J.; Bower, C. Fortification of flour with folic acid. Food. Nutr. Bull., 2010, 31(1 Suppl), S22-S35.
4. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. 1992, MMWR 41(No. RR-14)), 001.
5. McNulty, H.; Pentieva, K. Folate bioavailability. Proc. Nutr. Soc., 2004, 63(4), 529-536.
6. Qiu, A.; Jansen, M.; Sakaris, A.; Min, S.H.; Chattopadhyay, S.; Tsai, E.; Sandoval, C.; Zhao, R.; Akabas, M.H.; Goldman, I.D. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell., 2006, 127(5), 917-928.
7. Bailey, S.W.; Ayling, J.E. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci U. S. A., 2009, 106(36), 15424-15429.
8. Zhang, D.; Ochi, N.; Takigawa, N.; Tanimoto, Y.; Chen, Y.; Ichihara, E.; Hotta, K.; Tabata, M.; Tanimoto, M.; Kiura, K. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines. Cancer. Lett., 2011, 309(2), 228-235.
9. Kutzbach, C.; Stokstad, E.L. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. Biochim. Biophys. Acta., 1971, 250(3), 459-477.
10. Jencks, D.A.; Mathews, R.G. Allosteric inhibition of methylenetet- rahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J. Biol. Chem., 1987, 262(6), 2485-2493.
11. Wang, Y.C.; Tang, F.Y.; Chen, S.Y.; Chen, Y.M.; Chiang, E.P. Glycine-N methyltransferase expression in HepG2 cells is involved in methyl group homeostasis by regulating transmethylation kinetics and DNA methylation. J. Nutr., 2011, 141(5), 777-782.
12. Jacques, P.F.; Selhub, J.; Bostom, A.G.; Wilson, P.W.; Rosenberg, I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med., 1999, 340(19), 1449-1454.
13. Yang, Q.; Cogswell, M.E.; Hamner, H.C.; Carriquiry, A.; Bailey, L.B.; Pfeiffer, C.M.; Berry, R.J. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am. J. Clin. Nutr., 2010, 91(1), 64-72.
14. Bailey, R.L.; McDowell, M.A.; Dodd, K.W.; Gahche, J.J.; Dwyer, J.T.; Picciano, M.F. Total folate and folic acid intakes from foods and dietary supplements of US children aged 1-13 y. Am. J. Clin. Nutr., 2010, 92(2), 353-358.
15. Obeid, R.; Schorr, H.; Eckert, R.; Herrmann, W. Vitamin B12 status in the elderly as judged by available biochemical markers. Clin. Chem., 2004, 50(1), 238-241.
16. Lawrence, J.M.; Petitti, D.B.; Watkins, M.; Umekubo, M.A. Trends in serum folate after food fortification. Lancet., 1999, 354(9182), 915-916.
17. Flynn, A.; Hirvonen, T.; Mensink, G.B.; Ocke, M.C.; Serra-Majem, L.; Stos, K.; Szponar, L.; Tetens, I.; Turrini, A.; Fletcher, R.; Wildemann, T. Intake of selected nutrients from foods, from fortification and from supplements in various European countries. Food. Nutr. Res., 2009, 53.
18. Young, P.J.; Nicolas, G.; Freisling, H.; Biessy, C.; Scalbert, A.; Romieu, I.; Chajes, V.; Chuang, S.C.; Ericson, U.; Wallstrom, P.; Ros, M.M.; Peeters, P.H.; Mattiello, A.; Palli, D.; Maria, H.J.; Amiano, P.; Halkjaer, J.; Dahm, C.C.; Trichopoulou, A.; Orfanos, P.; Teucher, B.; Feller, S.; Skeie, G.; Engeset, D.; Boutron-Ruault, M.C.; Clavel-Chapelon, F.; Crowe, F.; Khaw, K.T.; Vineis, P.; Slimani, N. Comparison of standardised dietary folate intake across ten countries participating in the European Prospective Investigation into Cancer and Nutrition. Br. J. Nutr., 2011, 1-18.
19. Pfeiffer, CM.; Caudill, S.P.; Gunter, E.W.; Osterloh, J.; Sampson, E.J. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am. J. Clin. Nutr., 2005, 82(2), 442-450.
20. Yeung, L.F.; Cogswell, M.E.; Carriquiry, A.L.; Bailey, L.B.; Pfeiffer, CM.; Berry, R.J. Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children: National Health and Nutrition Examination Survey (NHANES), 2003-2006. Am. J. Clin. Nutr., 2011, 93(1), 172-185.
21. Zlotkin, S. A critical assessment of the upper intake levels for infants and children. J Nutr., 2006, 136(2), 502S-506S.
22. Pfeiffer, CM.; Johnson, C.L.; Jain, R.B.; Yetley, E.A.; Picciano, M.F.; Rader, J.I.; Fisher, K.D.; Mulinare, J.; Osterloh, J.D. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am. J. Clin. Nutr., 2007, 86(3), 718-727.
23. Hursthouse NA; Gray AR; Miller JC; Rose MC; Houghton LA Folate Status of Reproductive Age Women and Neural Tube Defect Risk: The Effect of Long-Term Folic Acid Supplementation at Doses of 140 ug and 400 ug per Day. Nutrients., 2011, 3(1), 49-62.
24. Choumenkovitch, S.F.; Selhub, J.; Wilson, P.W.; Rader, J.I.; Rosenberg, I.H.; Jacques, P.F. Folic acid intake from fortification in United States exceeds predictions. J. Nutr., 2002, 132(9), 2792-2798.
25. Quinlivan, E.P.; Gregory, J.F., III Effect of food fortification on folic acid intake in the United States. Am. J. Clin. Nutr., 2003, 77(1), 221-225.
26. Sunder-Plassmann, G.; Fodinger, M.; Buchmayer, H.; Papagiannopoulos, M.; Wojcik, J.; Kletzmayr, J.; Enzenberger, B.; Janata, O.; Winkelmayer, W.C.; Paul, G.; Auinger, M.; Barnas, U.; Horl, W.H. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J. Am. Soc. Nephrol, 2000, 11(6), 1106-1116.
27. Gonin, J.M.; Nguyen, H.; Gonin, R.; Sarna, A.; Michels, A.; Masri-Imad, F.; Bommareddy, G.; Chassaing, C.; Wainer, I.; Loya, A.; Cary, D.; Barker, L.F.; Assefi, A.; Greenspan, R.; Mahoney, D.; Wilcox, CS. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J. Nephrol, 2003, 16(4), 522-534.
28. Obeid R; Kirsch, S.H.; Kasoha M; Eckert R; Herrmann W Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metabolism, 2011, 60(5), 673-678.
29. Sweeney, M.R.; McPartlin, J.; Scott, J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC. Public. Health., 2007, 7, 41.
30. Kalmbach, R.D.; Choumenkovitch, S.F.; Troen, A.M.; D'Agostino, R.; Jacques, P.F.; Selhub, J. Circulating folic acid in plasma: relation to folic acid fortification. Am. J. Clin. Nutr., 2008, 88(3), 763-768.
31. Kelly, P.; McPartlin, J.; Goggins, M.; Weir, D.G.; Scott, J.M. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J Clin Nutr., 1997, 65(6), 1790-1795.
32. Bailey, R.L.; Mills, J.L.; Yetley, E.A.; Gahche, J.J.; Pfeiffer, C.M.; Dwyer, J.T.; Dodd, K.W.; Sempos, C.T.; Betz, J.M.; Picciano, M.F. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am. J. Clin. Nutr., 2010, 92(2), 383-389.
33. Pfeiffer, C.M.; Fazili, Z.; McCoy, L.; Zhang, M.; Gunter, E.W. Determination of folate vitamers in human serum by stable-isotopedilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin. Chem., 2004, 50(2), 423-432.
34. Houghton, L.A.; Sherwood, K.L.; Pawlosky, R.; Ito, S.; O'Connor, D.L. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am. J. Clin. Nutr., 2006, 83(4), 842-850.
35. Lucock, M.; Wild, J.; Smithells, R.; Hartley, R. Biotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis-Menten kinetics. Eur. J. Clin. Nutr., 1989, 43(9), 631-635.
36. Kirsch, S.H.; Knapp, J.P.; Herrmann, W.; Obeid, R. Quantification of key folate forms in serum using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry. J Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2010, 878(1), 68-75.
37. Obeid, R.; Kasoha, M.; Kirsch, S.H.; Munz, W.; Herrmann, W. Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am. J. Clin. Nutr., 2010, 92(6), 1416-1422.
38. Sweeney, M.R.; McPartlin, J.; Weir, D.G.; Daly, S.; Pentieva, K.; Daly, L.; Scott, J.M. Evidence of unmetabolised folic acid in cord blood of newborn and serum of 4-day-old infants. Br. J. Nutr., 2005, 94(5), 727-730.
39. Fohr, I.P.; Prinz-Langenohl, R.; Bronstrup, A.; Bohlmann, A.M.; Nau, H.; Berthold, H.K.; Pietrzik, K. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am. J. Clin. Nutr., 2002, 75(2), 275-282.
40. Stern, L.L.; Bagley, P.J.; Rosenberg, I.H.; Selhub, J. Conversion of 5-formyltetrahydrofolic acid to 5-methyltetrahydrofolic acid is unimpaired in folate-adequate persons homozygous for the C677T mutation in the methylenetetrahydrofolate reductase gene. J. Nutr., 2000, 130(9), 2238-2242.
41. Bagley, P.J.; Selhub, J. A common mutation in the methylenetetra- hydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc. Natl. Acad. Sci U. S. A., 1998, 95(22), 13217-13220.
42. Fazili, Z.; Pfeiffer, C.M.; Zhang, M.; Jain, R.B.; Koontz, D. Influence of 5,10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate concentrations measured by LC-MS/MS, microbiologic assay, and bio-rad radioassay. Clin. Chem., 2008, 54(1), 197-201.
43. Davis, S.R.; Quinlivan, E.P.; Shelnutt, K.P.; Maneval, D.R.; Ghandour, H.; Capdevila, A.; Coats, B.S.; Wagner, C.; Selhub, J.; Bailey, L.B.; Shuster, J.J.; Stacpoole, P.W.; Gregory, J.F., III The methylenetetrahydrofolate reductase 677C->T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J. Nutr., 2005, 135(5), 1040-1044.
44. Smulders, Y.M.; Smith, D.E.; Kok, R.M.; Teerlink, T.; Gellekink, H.; Vaes, W.H.; Stehouwer, C.D.; Jakobs, C. Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status. J. Nutr. Biochem., 2007, 18(10), 693-699.
45. Levine, A.J.; Figueiredo, J.C.; Lee, W.; Conti, D.V.; Kennedy, K.; Duggan, D.J.; Poynter, J.N.; Campbell, P.T.; Newcomb, P.; Martinez, M.E.; Hopper, J.L.; Le, M.L.; Baron, J.A.; Limburg, P.J.; Ulrich, C.M.; Haile, R.W. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol. Biomarkers. Prev., 2010, 19(7), 1812-1821.
46. De Brouwer, V.; Zhang, G.F.; Storozhenko, S.; Straeten, D.V.; Lambert, W.E. pH stability of individual folates during critical sample preparation steps in prevision of the analysis of plant folates. Phytochem. Anal., 2007, 18(6), 496-508.
47. Wright, A.J.; Finglas, P.M.; Dainty, J.R.; Hart, D.J.; Wolfe, C.A.; Southon, S.; Gregory, J.F. Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies. Br. J. Nutr., 2003, 90(2), 363-371.
48. Aufreiter, S.; Gregory, J.F., III; Pfeiffer, C.M.; Fazili, Z.; Kim, Y.I.; Marcon, N.; Kamalaporn, P.; Pencharz, P.B.; O'Connor, D.L. Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-labeled [6S]-5-formyltetrahydrofolic acid. Am. J. Clin. Nutr., 2009, 90(1), 116-123.
49. Wright, A.J.; Finglas, P.M.; Dainty, J.R.; Wolfe, C.A.; Hart, D.J.; Wright, D.M.; Gregory, J.F. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: a revised hypothesis of the primary site of PteGlu metabolism in humans. J. Nutr., 2005, 135(3), 619-623.
50. Ashokkumar, B.; Mohammed, Z.M.; Vaziri, N.D.; Said, H.M. Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am. J. Clin. Nutr., 2007, 86(1), 159-166.
51. De Meer, K.; Smulders, Y.M.; Dainty, J.R.; Smith, D.E.; Kok, R.M.; Stehouwer, C.D.; Finglas, P.M.; Jakobs, C. [6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults. Eur. J. Clin. Nutr., 2005, 59(12), 1409-1416.
52. Tighe, P.; Ward, M.; McNulty, H.; Finnegan, O.; Dunne, A.; Strain, J.; Molloy, A.M.; Duffy, M.; Pentieva, K.; Scott, J.M. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am. J. Clin. Nutr., 2011, 93(1), 11-18.
53. Verwei, M.; Arkbage, K.; Havenaar, R.; van den, B.H.; Witthoft, C.; Schaafsma, G. Folic acid and 5-methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J. Nutr., 2003, 133(7), 2377-2383.
54. Venn, B.J.; Green, T.J.; Moser, R.; Mann, J.I. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am. J. Clin. Nutr., 2003, 77(3), 658-662.
55. Basten, G.P.; Duthie, S.J.; Pirie, L.; Vaughan, N.; Hill, M.H.; Powers, H.J. Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br. J. Cancer, 2006, 94(12), 1942-1947.
56. Basten, G.P.; Hill, M.H.; Duthie, S.J.; Powers, H.J. Effect of folic Acid supplementation on the folate status of buccal mucosa and lymphocytes. Cancer Epidemiol. Biomarkers. Prev., 2004, 13(7), 1244-1249.
57. Jung, A.Y.; Smulders, Y.; Verhoef, P.; Kok, F.J.; Blom, H.; Kok, R.M.; Kampman, E.; Durga, J. No effect of folic Acid supplementation on global DNA methylation in men and women with moderately elevated homocysteine. PLoS One, 2011, 6(9), e24976.
58. Hazra, A.; Selhub, J.; Chao, W.H.; Ueland, P.M.; Hunter, D.J.; Baron, J.A. Uracil misincorporation into DNA and folic acid supplementation. Am. J. Clin. Nutr., 2010, 91(1), 160-165.
59. Chanson, A.; Parnell, L.D.; Ciappio, E.D.; Liu, Z.; Crott, J.W.; Tucker, K.L.; Mason, J.B. Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population. Am. J. Clin. Nutr., 2009, 89(6), 1927-1936.
60. Wang, X.; Fenech, M. A comparison of folic acid and 5- methyltetrahydrofolate for prevention of DNA damage and cell death in human lymphocytes in vitro. Mutagenesis., 2003, 18(1), 81-86.
61. Troen, A.M.; Mitchell, B.; Sorensen, B.; Wener, M.H.; Johnston, A.; Wood, B.; Selhub, J.; McTiernan, A.; Yasui, Y.; Oral, E.; Potter, J.D.; Ulrich, C.M. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among post-menopausal women. J. Nutr., 2006, 136(1), 189-194.
62. Erickson, K.L.; Medina, E.A.; Hubbard, N.E. Micronutrients and innate immunity. J. Infect. Dis., 2000, 182(Suppl 1), S5-10.
63. Kim, Y.I.; Hayek, M.; Mason, J.B.; Meydani, S.N. Severe folate deficiency impairs natural killer cell-mediated cytotoxicity in rats. J. Nutr., 2002, 132(6), 1361-1367.
64. Bonassi, S.; Znaor, A.; Ceppi, M.; Lando, C.; Chang, W.P.; Holland, N.; Kirsch-Volders, M.; Zeiger, E.; Ban, S.; Barale, R.; Bigatti, M.P.; Bolognesi, C.; Cebulska-Wasilewska, A.; Fabianova, E.; Fucic, A.; Hagmar, L.; Joksic, G.; Martelli, A.; Migliore, L.; Mirkova, E.; Scarfi, M.R.; Zijno, A.; Norppa, H.; Fenech, M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis., 2007, 28(3), 625-631.
65. Bonassi, S.; El-Zein, R.; Bolognesi, C.; Fenech, M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis., 2011, 26(1), 93-100.
66. Stopper, H.; Treutlein, A.T.; Bahner, U.; Schupp, N.; Schmid, U.; Brink, A.; Perna, A.; Heidland, A. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol. Dial. Transplant., 2008, 23(10), 3272-3279.
67. Kimura, M.; Umegaki, K.; Higuchi, M.; Thomas, P.; Fenech, M. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J. Nutr., 2004, 134(1), 48-56.
68. Duthie, S.J.; Horgan, G.; De, R.B.; Rucklidge, G.; Reid, M.; Duncan, G.; Pirie, L.; Basten, G.; Powers, H.J. Blood folate status and expression of proteins involved in immune function, inflammation and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J. Proteome. Res., 2010, 9(4), 1941-1950.
69. Mason, J.B.; Dickstein, A.; Jacques, P.F.; Haggarty, P.; Selhub, J.; Dallal, G.; Rosenberg, I.H. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer. Epidemiol. Biomarkers. Prev., 2007, 16(7), 1325-1329.
70. Hubner, R.A.; Houlston, R.S. Folate and colorectal cancer prevention. Br. J. Cancer, 2009, 100(2), 233-239.
71. Gibson, T.M.; Weinstein, S.J.; Pfeiffer, R.M.; Hollenbeck, A.R.; Subar, A.F.; Schatzkin, A.; Mayne, S.T.; Stolzenberg-Solomon, R. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am. J. Clin. Nutr., 2011, 94(4), 1053-1062.
72. Oaks, B.M.; Dodd, K.W.; Meinhold, C.L.; Jiao, L.; Church, T.R.; Stolzenberg-Solomon, R.Z. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr., 2010, 91(2), 449-455.
73. Song, J.; Medline, A.; Mason, J.B.; Gallinger, S.; Kim, Y.I. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer. Res., 2000, 60(19), 5434-5440.
74. Lindzon, G.M.; Medline, A.; Sohn, K.J.; Depeint, F.; Croxford, R.; Kim, Y.I. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis., 2009, 30(9), 1536-1543.
75. Stevens, V.L.; McCullough, M.L.; Sun, J.; Gapstur, S.M. Folate and other one-carbon metabolism-related nutrients and risk of post-menopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort. Am. J. Clin. Nutr., 2010, 91(6), 1708-1715.
76. Maruti, S.S.; Ulrich, C.M.; White, E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am. J. Clin. Nutr., 2009, 89(2), 624-633.
77. Stolzenberg-Solomon, R.Z.; Chang, S.C.; Leitzmann, M.F.; Johnson, K.A.; Johnson, C.; Buys, S.S.; Hoover, R.N.; Ziegler, R.G. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr., 2006, 83(4), 895-904.
78. Chen, L.; Qi, H.; Korenberg, J.; Garrow, T.A.; Choi, Y.J.; Shane, B. Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene. J. Biol. Chem., 1996, 271(22), 13077-13087.
79. Lindenbaum, J.; Healton, E.B.; Savage, D.G.; Brust, J.C.; Garrett, T.J.; Podell, E.R.; Marcell, P.D.; Stabler, S.P.; Allen, R.H. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med., 1988, 318(26), 1720-1728.
80. Carmel, R.; Sinow, R.M.; Karnaze, D.S. Atypical cobalamin deficiency. Subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J. Lab. Clin. Med., 1987, 109(4), 454-463.
81. van Beynum, I.; Kapusta, L.; Bakker, M.K.; den Heijer M.; Blom, H.J.; de Walle, H.E. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur. Heart. J., 2010, 31(4), 464-471.
82. Mosley, B.S.; Cleves, M.A.; Siega-Riz, A.M.; Shaw, G.M.; Canfield, M.A.; Waller, D.K.; Werler, M.M.; Hobbs, C.A. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am. J. Epidemiol., 2009, 169(1), 9-17.
83. Veena, S.R.; Krishnaveni, G.V.; Srinivasan, K.; Wills, A.K.; Muthayya, S.; Kurpad, A.V.; Yajnik, C.S.; Fall, C.H. Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9-to 10-year-old children in South India. J. Nutr., 2010, 140(5), 1014-1022.
84. Sweeney, M.R.; Staines, A.; Daly, L.; Traynor, A.; Daly, S.; Bailey, S.W.; Alverson, P.B.; Ayling, J.E.; Scott, J.M. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health, 2009, 9, 295.
85. Bodnar, L.M.; Himes, K.P.; Venkataramanan, R.; Chen, J.Y.; Evans, R.W.; Meyer, J.L.; Simhan, H.N. Maternal serum folate species in early pregnancy and risk of preterm birth. Am. J. Clin. Nutr., 2010, 92(4), 864-871.
86. Shaw, G.M.; Carmichael, S.L.; Nelson, V.; Selvin, S.; Schaffer, D.M. Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public. Health. Rep., 2004, 119(2), 170-173.
87. Gomes, T.S.; Lindner, U.; Tennekoon, K.H.; Karandagoda, W.; Gortner, L.; Obeid, R. Homocysteine in small-for-gestational age and appropriate-for- gestational age preterm neonates from mothers receiving folic acid supplementation. Clin. Chem. Lab. Med., 2010, 48(8), 1157-1161.
88. Chatzi, L.; Papadopoulou, E.; Koutra, K.; Roumeliotaki, T.; Georgiou, V.; Stratakis, N.; Lebentakou, V.; Karachaliou, M.; Vassilaki, M.; Kogevinas, M. Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort 'Rhea' study in Crete, Greece. Public. Health. Nutr., 2012, 8, 1-9.
89. Achon, M.; Reyes, L.; onso-Aperte, E.; Ubeda, N.; Varela-Moreiras, G. High dietary folate supplementation affects gestational development and dietary protein utilization in rats. J. Nutr., 1999, 129(6), 1204-1208.
90. Bukowski, R.; Malone, F.D.; Porter, F.T.; Nyberg, D.A.; Comstock, C.H.; Hankins, G.D.; Eddleman, K.; Gross, S.J.; Dugoff, L.; Craigo, S.D.; Timor-Tritsch, I.E.; Carr, S.R.; Wolfe, H.M.; D'Alton, M.E. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS. Med., 2009, 6(5), e1000061.
91. Haberg, S.E.; London, S.J.; Stigum, H.; Nafstad, P.; Nystad, W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch. Dis. Child., 2009, 94(3), 180-184.
92. Haberg, S.E.; London, S.J.; Nafstad, P.; Nilsen, R.M.; Ueland, P.M.; Vollset, S.E.; Nystad, W. Maternal folate levels in pregnancy and asthma in children at age 3 years. J. Allergy. Clin. Immunol., 2011, 127(1), 262-4, 264.
93. Zhang, T.; Xin, R.; Gu, X.; Wang, F.; Pei, L.; Lin, L.; Chen, G.; Wu, J.; Zheng, X. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public. Health. Nutr., 2009, 12(5), 680-686.
94. Whitrow, M.J.; Moore, V.M.; Rumbold, A.R.; Davies, M.J. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am. J. Epidemiol., 2009, 170(12), 1486-1493.
95. Magdelijns, F.J.; Mommers, M.; Penders, J.; Smits, L.; Thijs, C. Folic Acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics., 2011, 128(1), e135-e144.
96. Martinussen, M.P.; Risnes, K.R.; Jacobsen, G.W.; Bracken, M.B. Folic acid supplementation in early pregnancy and asthma in children aged 6 years. Am. J. Obstet. Gynecol., 2012, 206(1), 72e1-7.
97. Bekkers, M.B.; Elstgeest, L.E.; Scholtens, S.; Haveman, A.; de Jongste, J.C.; Kerkhof, M.; Koppelman, G.H.; Gehring, U.; Smit, H.A.; Wijga, A.H. Maternal use of folic acid supplements during pregnancy and childhood respiratory health and atopy: the PIAMA birth cohort study. Eur. Respir. J., 2011, In press. PMID: 22034647.
98. Stewart, C.P.; Christian, P.; Schulze, K.J.; LeClerq, S.C.; West, K.P., Jr.; Khatry, S.K. Antenatal micronutrient supplementation reduces metabolic syndrome in 6-to 8-year-old children in rural Nepal. J. Nutr., 2009, 139(8), 1575-1581.
99. Steegers-Theunissen, R.P.; Obermann-Borst, S.A.; Kremer, D.; Lindemans, J.; Siebel, C.; Steegers, E.A.; Slagboom, P.E.; Heijmans, B.T. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One, 2009, 4(11), e7845.
100. Sie, K.K.; Medline, A.; van Weel, J.; Sohn, K.J.; Choi, S.W.; Croxford, R.; Kim, Y.I. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring. Gut, 2011, 60(12), 1687-1694.